Entero Therapeutics Inc. (ENTO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Entero Therapeutics Inc.

    NASDAQ: ENTO · Real-Time Price · USD
    2.30
    -0.18 (-7.26%)
    At close: Sep 11, 2025, 3:58 PM
    2.30
    0.00%
    After-hours: Sep 11, 2025, 04:04 PM EDT

    Entero Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 163.48K 3.71M 1.36M 8.25M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 21.52K 21.52K 21.51K n/a
    Other Long-Term Assets
    		 98.25K 11.25K 39.66K 44.01K
    Receivables
    		 n/a n/a 93.01K n/a
    Inventory
    		 n/a n/a 1.95M n/a
    Other Current Assets
    		 83.17M n/a n/a n/a
    Total Current Assets
    		 83.48M 4.96M 3.41M 9.42M
    Property-Plant & Equipment
    		 126.75K 210K 303.1K 409.31K
    Goodwill & Intangibles
    		 1.68M 1.68M 1.68M 1.91M
    Total Long-Term Assets
    		 1.93M 1.93M 2.03M 2.37M
    Total Assets
    		 85.41M 6.88M 5.44M 11.79M
    Account Payables
    		 2.96M 554.28K 720.04K 2.71M
    Deferred Revenue
    		 n/a n/a 1.08M 8.86M
    Short-Term Debt
    		 81.51K 612.78K 603.49K 641.24K
    Other Current Liabilities
    		 22.86M 1.4M 12.14K 14.82K
    Total Current Liabilities
    		 27.55M 3.13M 2.48M 12.3M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a 7M
    Total Long-Term Liabilities
    		 59.02K 146.95K 214.06K 7.31M
    Total Liabilities
    		 27.61M 3.28M 2.7M 19.61M
    Total Debt
    		 140.53K 826.84K 883.71K 1.03M
    Common Stock
    		 475.00 156.00 5.00 7.00
    Retained Earnings
    		 -202.39M -184.33M -168.53M -153.9M
    Comprehensive Income
    		 n/a 0.00 n/a -1.22M
    Shareholders Equity
    		 57.8M 3.6M 2.74M -7.82M
    Total Investments
    		 21.52K 21.52K 21.51K n/a

    Add to Watchlist